SIG BROKERAGE, LP
Broker-DealerPosition in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 1094429
BALA CYNWYD, PA
Position in DNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,398,008
+$695,104 QoQ
Shares Held
24,600
+21.2% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#131
of 270 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIG BROKERAGE, LP holds $14,503,065 across 7 Biotechnology names. DNTH ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,390 | $11,121,784 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
24,600 | $2,398,008 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
2,846 | $532,998 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
6,563 | $308,723 | |
| 5 | GALT |
Galectin Therapeutics Inc
|
13,596 | $63,085 | |
| 6 | NMRA |
Neumora Therapeutics, Inc.
|
27,483 | $46,721 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
|
14,496 | $31,746 |
All Filings in DNTH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,398,008 | 24,600 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,702,904 | 20,292 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||